Treatment of vitamin B12 deficiency. Evaluation of therapy with cyanocobalamin, hydroxocabalamin, and depot cobalamin Betolvex.
D000284:Administration, Oral; D000752:Anemia, Pernicious / Q000188:drug therapy*; D003692:Delayed-Action Preparations; D004912:Erythrocytes; D006454:Hemoglobins / Q000378:metabolism; D006801:Humans; D006879:Hydroxocobalamin / Q000008:administration & dosage / Q000627:therapeutic use*; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D007437:Intrinsic Factor; D011178:Postgastrectomy Syndromes / Q000517:prevention & control; D012546:Schilling Test; D013997:Time Factors; D014805:Vitamin B 12 / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use*; D014806:Vitamin B 12 Deficiency / Q000097:blood / Q000188:drug therapy* / Q000517:prevention & control
D003692:Delayed-Action Preparations; D006454:Hemoglobins; D007437:Intrinsic Factor; D014805:Vitamin B 12; D006879:Hydroxocobalamin